RecruitingNot ApplicableNCT07414719

Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Prospective, Randomized, Cluster-controlled, Multicenter Study to Evaluate the Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.


Sponsor

Centre Leon Berard

Enrollment

1,422 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed. Today, only 40.7% of adolescents are vaccinated in France, and the Auvergne Rhône Alpes region remains below the targets (47.5% for girls and 12.3% for boys). This is still far from the national target of 80% vaccination coverage by 2030, while 6,400 new cases of HPV-related cancers are reported each year. The PIMCOP regional study aims to assess the impact of a primary prevention intervention, co-developed with stakeholders and implemented in middle and high schools, on the HPV vaccination rate at 6 months among 11-17 year olds.


Eligibility

Min Age: 11 YearsMax Age: 17 Years

Inclusion Criteria11

  • Girl or boy, student at a public school participating in the study
  • Aged 11 to 17
  • Having received an information sheet about the study and having signed a declaration of non-objection
  • Whose parents have also received an information sheet and have not expressed their non-objection
  • Able to read, write, and understand French
  • Affiliated with the SS or equivalent
  • Male or female, teacher at a public school participating in the study and supervising a participating class
  • Aged 18 or over
  • Having received an information sheet about the study and not having expressed their opposition
  • Able to read, write, and understand French
  • Affiliated with the SS or equivalent

Exclusion Criteria2

  • children protected by the law
  • \- Person specially protected by law

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHPV animation

This presentation will enable young people to gather key information about HPV: - What is it? - How is it transmitted? - Who is affected? - What are the possible consequences? - How can you protect yourself? To this end, it was decided to hold a 1.5-hour presentation for 9th grade classes in middle school and 12th grade classes in high school. This presentation consists of a discussion with the students about the five key pieces of information mentioned above, followed by a game to find the locations of possible cancers linked to HPV infection. Materials have been created to help facilitate this presentation, including five posters with the key messages to convey to students and the silhouette game (consisting of different cancer location markers).


Locations(1)

Lycée BELTRAME

Saint-Priest, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07414719